I just took whats left of my compounded triz and it wasn’t a full dose

Status
Not open for further replies.

Atlanatpr

GLP-1 Apprentice
Member Since
Mar 29, 2026
Posts
55
Likes Received
116
Location
Austin
So I’m supposed to be taking 125 Units (10mg), and I only had 42 because fucking PayPal refuses to give me my money for 120 days, and I couldn’t buy more, and I’m extremely hesitant to order and mix myself because of safety and no group testing or any filters or anything, so instead I’m hoping I’ll have more money this upcoming week around Wednesday to buy more. When I do, should I take a full dose? Or start over at the lowest dose and build up again? Or what? I’d love some advice about what to do in general
 
woundcarping said:
The timing of the next dose matters for any meaningful advice. If it's taken next week vs 2 weeks vs 2 months etc.
I’ll probably take it as soon as I get it and will get it either Friday or Tuesday probably. My last full dose was not this Sunday (Today) But last week
 
Atlanatpr said:
I’ll probably take it as soon as I get it and will get it either Friday or Tuesday probably. My last full dose was not this Sunday (Today) But last week

So 10mg last Sunday, 3.3mg this Sunday.

Assuming you’re not sensitive/minimal side effects, you’ve been set 10mg for weeks, without running the math:

If you get it Friday I’d take ~6-8mg Friday and the balance Monday, then back to regular programming the following Sunday.

If you didn’t get it until Tuesday I might would do something like 6mg Tuesday, 2mg Thursday or Friday, 10mg Monday, regular scheduling the following Sunday.

The biggest thing is you don’t want to rocket your peak way beyond where it’s been. I’m a split dosing, fast titrating, minimal side effect kinda guy, so splitting the doses to ramp back in fits my way of thinking very well.
 
So, not trying to throw shade on you, just a genuine question. Why are you here instead of on the compound tirz forums on reddit if the gray market worries you so much?

I mean, this entire forum is about shooting Chinese ??? Into your body, and even with testing is pretty sus 😅 as those fuckers could be brewing this stuff up in dirty basements and smoking opium/petting thier mangy cat as they put it together.

We just dont know.
 
I have inhaled, ingested and injected some questionable stuff in my life 70+years. Never worried too much about it, and i am still alive. I see many here worried about +-.01 mg or a day late or a day early on the doseage. Your body will tell you what you need to do. Just listen to it..
 
125 units seems like a lot of fluid to unnecessarily pin at once.

What makes you think your compounding pharmacy has tested anything (mass, purity, sterility, endotoxins) when they've bought the exact same grey vials from China that you would? Or has more sanitary conditions than your home? Or cares?

However you handle the gap (which doesn't make a big difference anyway; you'll either overeat or undereat for a week or whatever), please spend the time reading the relevant sections of these forums and plan on switching quickly to grey ... all sections are unlocked to you, including ones to choose a vendor and the one that helps get you over the fear of multihop crypto use (a necessary pain in the ass). Compounders are a bottomless pit and offer nothing but a false sense of security at 10x the price. Donate the difference to The Poor.
 
indolent said:
125 units seems like a lot of fluid to unnecessarily pin at once.

What makes you think your compounding pharmacy has tested anything (mass, purity, sterility, endotoxins) when they've bought the exact same grey vials from China that you would? Or has more sanitary conditions than your home? Or cares?

However you handle the gap (which doesn't make a big difference anyway; you'll either overeat or undereat for a week or whatever), please spend the time reading the relevant sections of these forums and plan on switching quickly to grey ... all sections are unlocked to you, including ones to choose a vendor and the one that helps get you over the fear of multihop crypto use (a necessary pain in the ass). Compounders are a bottomless pit and offer nothing but a false sense of security at 10x the price. Donate the difference to The Poor.
and I'm the poor
 
indolent said:
125 units seems like a lot of fluid to unnecessarily pin at once.

What makes you think your compounding pharmacy has tested anything (mass, purity, sterility, endotoxins) when they've bought the exact same grey vials from China that you would? Or has more sanitary conditions than your home? Or cares?

However you handle the gap (which doesn't make a big difference anyway; you'll either overeat or undereat for a week or whatever), please spend the time reading the relevant sections of these forums and plan on switching quickly to grey ... all sections are unlocked to you, including ones to choose a vendor and the one that helps get you over the fear of multihop crypto use (a necessary pain in the ass). Compounders are a bottomless pit and offer nothing but a false sense of security at 10x the price. Donate the difference to The Poor.
It’s pretty simple for me. I like that you can sue compounders if something goes wrong. And it’s cheaper than main, and the peace of mind is definitely worth it for me. It’s not for everyone, and that’s okay.
 
While it does seem intimidating, you don't have to jump in the water all at once. Read, watch videos on reconstituting, put together a list of items you will need and start getting them. Maybe buy one or two needed items per payday till you have everything you need. Once you have the gear, buy your glp1 kit. You have to eat the elephant one bite at a time. Everything you need and the kit that will last you for some time depending on your dosage, will be cheaper than the quarterly compounded price. Taking your time and reading will allow you to form your own risk and safety levels, and then you will be able to move forward with confidence, rather than looking at all the stuff you need and feeling overwhelmed. Even if you decide to stay with compounded, it never hurts to have a backup plan. You can buy what you need for recon and one kit over time and put it away for a rainy day like you are facing now. Just knowing you have it will make you feel more secure, even if you never decide to use it.
 
Like @Gr33dyOctopus said, you appear lost. I get it, the name is confusing. It should be graymarketpeptidesmostlyglpsbutsomeotherthingstoo.com but that was taken so we had to go with glp1forum.com
 
Atlanatpr said:
It’s pretty simple for me. I like that you can sue compounders if something goes wrong. And it’s cheaper than main, and the peace of mind is definitely worth it for me. It’s not for everyone, and that’s okay.
Someone I was talking to about gray said the same thing to me before - I want to have someone to sue.

So I asked Google Gemini: has anyone successfully sued a glp1 compounder for damages?

The short answer is no.

The long answer is much more nuanced. For those who are curious, here it is:

As of mid-2026, there are no publicly documented instances of a patient successfully winning a trial or securing a finalized, public damages settlement in a product liability or personal injury lawsuit specifically against a GLP-1 compounding pharmacy.

While the litigation landscape surrounding GLP-1 receptor agonists (like semaglutide and tirzepatide) is exploding, the legal actions are divided into a few distinct categories—none of which have yet resulted in a landmark damages victory for an individual plaintiff against a compounder.

1. Individual Patient Lawsuits (Mass Torts) Focus on Brand Names​[archived internal link]
The vast majority of high-profile patient lawsuits alleging severe damages—such as gastroparesis (stomach paralysis), deep vein thrombosis, or bowel obstructions—have been directed at the innovator brand-name manufacturers (Novo Nordisk and Eli Lilly), not the compounding pharmacies (Ferrara, 2026; Rivard, 2025).

The MDL Context: These individual personal injury cases have largely been consolidated into a Multidistrict Litigation (MDL 3094, In Re: GLP-1 RAs Products Liability Litigation ) in the Eastern District of Pennsylvania (Ferrara, 2026).

The Legal Hurdle: These cases are still in the early stages of navigating complex pharmaceutical defense hurdles, such as proving medical causation and addressing "failure-to-warn" claims under the learned intermediary doctrine (Ferrara, 2026).

2. Consumer Class Actions Against Compounders Are Active but Pending​[archived internal link]
Rather than individual injury lawsuits, telehealth platforms and compounding entities that distribute off-brand GLP-1 formulations are primarily facing consumer protection and false advertising class action lawsuits .

The Hims & Hers Litigation: For example, a major class action complaint ( Donoho et al. v. Hims & Hers Health, Inc. ) was filed in early 2026 (COMPLAINT, 2026). The plaintiffs allege that the company misled consumers by marketing their compounded product as having "the same active ingredient" as Ozempic® and Wegovy®, when it allegedly contained different peptide collections and lacked FDA evaluation (COMPLAINT, 2026).

The Status: These lawsuits seek financial damages for deceptive trade practices, but they are ongoing and have not yet reached a final judgment or public payout.

3. Big Pharma vs. The Compounders​[archived internal link]
The entities currently suing compounding pharmacies with the most frequency are Eli Lilly and Novo Nordisk themselves, rather than patients (Xia, 2026).

The Claims: The brand manufacturers have filed dozens of lawsuits against medical spas, wellness clinics, and compounding pharmacies (such as Eli Lilly v. Valhalla Vitality and Novo Nordisk v. Brooksville Pharmaceuticals ) (DEMANDED, 2025; COMPLAINT, 2023).

The Goal: These are not personal injury cases; they are trademark infringement, patent protection, and unfair competition lawsuits aimed at stopping the sale of unapproved knockoffs (Kumar, 2023; Xia, 2026). While some of these have resulted in federal injunctions forcing spas or compounders to stop selling their products, they do not represent a patient recovering damages for health injuries.

Summary of Obstacles for Patients​[archived internal link]
If a patient attempts to sue a compounder for physical damages (like a 10-fold dosing overdose, which is a documented risk with compounder-provided loose vials and syringes), they typically face a fragmented legal route (Lambson et al., 2023). Because compounding pharmacies are regulated primarily by state boards of pharmacy rather than uniform FDA approvals, establishing a clear line of liability for a systemic design defect is much more legally fractured than suing a mass-manufacturer (Ferrara, 2026; Pearson, 2025).

Most legal experts view the GLP-1 space as an "emerging mass tort crisis," meaning successful damages verdicts or global settlements—if they happen—are likely still a few years away (Ferrara, 2026).

References​[archived internal link]

COMPLAINT, C. A. (2026). Donoho et al. v. Hims & Hers et al. - 1:26-cv-01954 - Class Action Lawsuits. United States District Court Northern District of Illinois .Cited by: 1

COMPLAINT, F. A. (2023). Novo Nordisk Inc. v. Brooksville Pharmaceuticals. United States District Court Middle District of Florida .

DEMANDED, J. (2025). Eli Lilly and Company v. Valhalla Vitality LLC. United States District Court Eastern District of New York .

Ferrara, A. (2026). GLP-1 Drugs and the Emerging Mass Tort Crisis: Navigating Legal Risks and Regulatory Gaps. UMKC Law Review , 94 (3), 732.

Kumar, S. (2023). Compounding Inequities Through Drug IP and Unfair Competition. Washington University Law Review , 102 , 371.Cited by: 10

Lambson, J. E., Flegal, S. C., & Johnson, A. R. (2023). Administration errors of compounded semaglutide reported to a poison control center—Case series. Journal of the American Pharmacists Association , 63 (5), 1643–1645. https://doi.org/10.1016/j.japh.2023.06.017Cited by: 40

Pearson, S. D. (2025). Affordable Access to GLP-1 Obesity Medications: Strategies to Guide Market Action and Policy Solutions. Institute for Clinical and Economic Review (ICER) White Paper .Cited by: 40

Rivard, A. (2025). The Debate Surrounding Ozempic and Other “Miracle” Weight Loss Drugs Situated in the Scholarly and Public Spheres (Honors Thesis). Roger Williams University.

Xia, W. (2026). Light on the Scale, Heavy on the Problems: How Telehealth's Accessible Weight Loss Solution Has Compounded Its Risks. Seton Hall Legislative Journal .Cited by: 1
 
Of all the problems in life, proselytizing gray market peptides to someone who’s short on time and money isn’t high on my list of priorities. Get past the most immediate issue, then worry about the possible improvements.

Someone in “crisis” probably shouldn’t try to learn several new things they’re uncomfortable with and expect to execute them adequately to ameliorate the current crisis.
 
Interesting thread. OP, do you basically have not money to pay for product, or is PP just limiting what you can get?
 
BNLFL said:
Interesting thread. OP, do you basically have not money to pay for product, or is PP just limiting what you can get?
It would seem as though their limited funds are tied up with PayPal and hopefully next Wednesday they’ll have enough outside of PayPal to buy another round of compounded peptide.
 
Introducing compounded users to the forum:

[Imported image pending local asset: attachments-scum-wretched-gif.23680]
 
Status
Not open for further replies.

Trending content

Members online

No members online now.

Forum statistics

Threads
2,620
Messages
55,146
Members
1
Latest member
Admin
Back
Top